This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
X
MM+Cover+small+181214
Categories:Investments

Himsworth shuns pharms in UK opps fund

  • Print
  • Comment

Eden Financial UK equity fund manager Leigh Himsworth says he is avoiding pharmaceuticals in his new UK select opportunities fund.

Last week, Eden launched the fund for former Gartmore manager Himsworth.

It will typically have around a third in FTSE 100 companies, a third in FTSE mid 250 and a third in small caps. It will hold between 40 and 60 stocks and no stock will have more than a 5 per cent position. The fund launches with seed money of £10m and the average market capitalisation of the companies invested in will be £4bn.

Himsworth says he is avoiding pharmaceuticals in the short term as they have rebounded strongly during the market volatility in August. He says: “The problem with pharmaceuticals is that the large caps are the only investable companies. There are only a few companies I can look at and I am trying to run diversified portfolio positions. I might end up drifting down the cap scale as it is easier to add value with smaller companies with less analysts covering them.”

Himsworth adds that while he is avoiding UK banks, he sees value in asset management companies as they have cash reserves, 5 per cent yields and there is consolidation in the industry.

Chelsea Financial Services managing director Darius McDermott says: “Himsworth had a very good track record at Rensburg Sheppard and Royal London and went in to resuscitate the Gartmore portfolios but his performance was disappointing. However, his long-term record is good.”

  • Print
  • Comment

Daily Email Updates
If you enjoyed this article, sign up to receive the latest news and analysis from Money Marketing.

The Money Marketing CPD Centre
Build your annual CPD - you can log and plan your CPD hours for free with The Money Marketing CPD Centre.

Money Marketing Awards 2015
Put your firm forward as the leading practitioner in your field. Adviser and Advertising categories are open to entries - Enter Now.

Have your sayEdit my profile/screen name

You must sign in to make a comment

AXA Wealth


Fund Data

Editor's Pick



Poll

Will providers be forced to pay out compensation over annuity misselling?

Job of the week

Latest jobs

View all jobs

Most recent comments

View more comments